Consolidated figures · ₹ crore
| ₹ Cr | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3,317 | 3,711 | 974 | 1,002 | 1,086 | 1,050 | 1,000 | 1,078 | 1,197 | 1,186 | 1,182 | 1,311 | |
| COGS | 959 | 1,072 | 232 | 229 | 237 | 247 | 225 | 247 | 271 | 267 | 263 | 292 |
| Gross profit | 2,357 | 2,639 | 742 | 773 | 849 | 803 | 775 | 831 | 926 | 918 | 919 | 1,019 |
| 1,987 | 2,083 | 585 | 612 | 632 | 617 | 593 | 629 | 690 | 716 | 695 | 763 | |
| 370 | 556 | 156 | 161 | 217 | 186 | 182 | 202 | 236 | 203 | 224 | 256 | |
| OPM % | 11.2% | 15% | 16.1% | 16.1% | 20% | 17.7% | 18.2% | 18.7% | 19.7% | 17.1% | 19% | 19.5% |
| Depreciation | 227 | 232 | 58 | 60 | 62 | 62 | 64 | 63 | 66 | 68 | 67 | 69 |
| Interest | 102 | 99 | 30 | 29 | 31 | 31 | 32 | 31 | 31 | 31 | 30 | 31 |
| -46 | 8 | -40 | 5,120 | 35 | 9 | 5 | 29 | 28 | -0 | 37 | -77 | |
| Profit before tax | -5 | 233 | 28 | 5,191 | 159 | 102 | 91 | 136 | 167 | 103 | 163 | 78 |
| Tax | 10 | 24 | 31 | 39 | 53 | 37 | 5 | 43 | 46 | 44 | 10 | 49 |
| Tax % | 197.1% | 10.4% | 107.6% | 0.8% | 33.3% | 36.8% | 5.5% | 31.4% | 27.3% | 43.1% | 6% | 62.5% |
| -15 | 209 | -2 | 5,152 | 106 | 64 | 86 | 94 | 121 | 59 | 154 | 29 | |
| PAT margin % | -0.5% | 5.6% | -0.2% | 514.3% | 9.7% | 6.1% | 8.6% | 8.7% | 10.1% | 5% | 13% | 2.2% |
| EPS (₹) | -0.6 | 3.6 | -0.5 | 103.3 | 1.9 | 1.1 | 1.6 | 1.7 | 2.1 | 1 | 2.7 | 0.3 |
| Results filing | — | — | — | — | — | — | — | Results filing for Jun 2025 | Results filing for Sep 2025 | — | Results filing for Mar 2026 | — |
| vs same quarter last year | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % | +17.8% | +16.2% | -70.2% | -68.8% | -67.2% | -71.7% | +2.7% | +7.6% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 30 Jun 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed |
|---|---|---|---|---|---|
| Hospitals & Clinics | 1,277.63 | 238.92 | 6,974.03 | 3,041.42 | 3,932.61 |
| Labs | 41.46 | 2.92 | 85.35 | 59.77 | 25.58 |
| +10.2% |
| +12.9% |
| +18.2% |
| +21.6% |
| PAT YoY % | -128.3% | +31.6% | -101.2% | +25,855.7% | — | -69.2% | — | -98.2% | +14.7% | -8.9% | +79.5% | -68.7% |
| Wholesale Pharmacies | 30.43 | 0.52 | 49.13 | 8.63 | 40.5 |
| Others | 1.56 | -0.61 | 26.6 | 0 | 26.6 |
| 0 | 0 | 0 | 0 | 0 | — |
₹ crore by quarter